Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 21, 2021; 27(39): 6572-6589
Published online Oct 21, 2021. doi: 10.3748/wjg.v27.i39.6572
Published online Oct 21, 2021. doi: 10.3748/wjg.v27.i39.6572
Figure 1 Management of resectable pancreatic adenocarcinoma.
5-FU: 5-Fluorouracil; ECOG: Eastern Cooperative Oncology Group.
Figure 2
Management of borderline resectable/locally advance pancreatic carcinoma.
Figure 3 Management of advanced metastatic pancreatic carcinoma.
ECOG: Eastern Cooperative Oncology Group; ULN: Upper limit of normal.
Figure 4 Palliative management in metastatic pancreatic carcinoma.
ERCP: Endoscopic retrograde cholangiopancreatography; EUS: Endoscopic ultrasound; EUS-BD: Endoscopic ultrasound guided biliary drainage; GJ: Gastrojejunostomy; HJ: Hepaticojejunostomy; PTBD: Percutaneous transhepatic biliary drainage; SEMS: Self-expanding metal stent.
- Citation: Manrai M, Tilak TVSVGK, Dawra S, Srivastava S, Singh A. Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities. World J Gastroenterol 2021; 27(39): 6572-6589
- URL: https://www.wjgnet.com/1007-9327/full/v27/i39/6572.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i39.6572